Biophoton Therapy and Quality of Life of Children with Chronic Complaints and Food Hypersensitivities

Thesis to obtain the academic degree Master of Science (MSc) at the Interuniversity College for Health and Development Graz / Castle of Seggau (college@inter-uni.net, www.inter-uni.net) presented by Pet-Reatsch Ellen Pet Wim Graz, November 2010 Pet-Reatsch Ellen and Pet Wim, MSc Thesis 2010 Interuniversity College Graz/Seggau 2 

The presented thesis was prepared as proof of scientific work within the prescribed time period. The presented thesis gives an interesting compilation of basic materials on the selected topic. It provides a basis for further research and, after appropriate revision, publication. Thesis accepted Graz, November 2010 Pet-Reatsch Ellen and Pet Wim, MSc Thesis 2010 Interuniversity College Graz/Seggau 3 Summary Authors: Ellen Pet-Reatsch, Wim Pet Supervisor: Chris Endler The purpose of the presented research is to investigate the influence of Biophoton Therapy on chronic complaints among children and adolescents. A subgroup of the treated individuals stated that their experienced complaints where a consequence of a diagnosed food hypersensitivity. The main focus of the study lies with the effect on the frequency of occurrence of chronic complaints among children and adolescents and the possible improvement of their quality of life. An important aspect of the subject under investigation is that there will be spoken of "chronic complaints" instead of "chronic disorders". A chronic disorder can only be diagnosed by a medical doctor, through valid methods or instruments according to professional standards. Chronic complaints, as opposed to disorders, can be determined by the child or adolescent itself and by their parents or guardians. To differentiate between incidental complaints and chronic complaints, and to define, in the first four criteria, what is meant in this study as a "chronic complaint among children", we will use the following inclusion criteria: • The complaint occurs with children and adolescents up to and including 18 years of age. • The complaint interferes with the child's normal daily routine(s). • The complaint can be self-identified and is not (per se) based on a medical diagnosis. • The complaint occurs frequently, i.e. daily or at least several times a week. The complaint had lasted for 3 months or a longer period of time already. • The child is not using any drugs and is (currently) not under treatment of a medical doctor. The research is set up as an open, not controlled, not randomised, observational study and was carried out among a group of 20 children and adolescents who suffered from chronic complaints. With 11 of the 20 children and adolescents, the parents or guardians of these individuals reported that the experienced complaints might be due to a food hypersensitivity that has been diagnosed by a medical doctor. Biophoton Therapy, as applied in this research, consists of personalised treatment that is determined by measurement with the 'Biophoton Therapy Device by J. Boswinkel', where after the actual treatment is also given through the 'Biophoton Therapy Device by J. Boswinkel'. There will not be any physically tangible treatment, such as drugs, herbs or any other substances. Before the beginning of the treatments, a questionnaire was filled out by the parents to establish the frequency of occurrence of the chronic complaints the child was suffering from. The Biophoton Therapy treatments all took place in the first 2 weeks of a 13-week period. At the end of the 13-week period, thus after a minimum of 11 weeks after the last treatment, the same questionnaire was filled out to assess the frequency of occurrence of the complaints of the individual. The frequency of the experienced chronic complaints will also be used as a measure for the quality of life. This can be inferred because "complaints" refer to those symptoms that affect the Pet-Reatsch Ellen and Pet Wim, MSc Thesis 2010 Interuniversity College Graz/Seggau 4 quality of life in a negative way, otherwise the symptoms would not be conceived as "complaints" by the parents and children or adolescents. The total group of 20 children and adolescents whose questionnaires were analysed began the treatment with an average of 6.7 chronic complaints per individual. Of a total of 133 chronic complaints, 92.5% of the chronic complaints were resolved. This means that after treatment the complaint did not occur anymore, or, in some cases, not frequently enough to count as a chronic complaint according to the outlined inclusion criteria of a chronic complaint as used in this study. Most of the chronic complaints that were not entirely resolved did improve, in the sense that the complaint occurred less frequent than before the treatment. Of all 133 chronic complaints, 97.0% improved in their frequency of occurrence. The food hypersensitivity subgroup consisted of 11 children and adolescents whose parents or guardians stated that their complaints where a consequence of a diagnosed allergic or non-allergic food hypersensitivity. Among those 11 children and adolescents, 86 chronic complaints were reported that met the inclusion criteria and they began the treatment with an average of 7.8 chronic complaints. Of the 86 chronic complaints among the 11 children and adolescents, 90.7% of the chronic complaints were totally resolved after treatment or reduced to only occur sporadically and 95.3% of the complaints improved in their frequency of occurrence. The results of this observational study show that Biophoton Therapy given with the 'Biophoton Therapy Device by J. Boswinkel' decreases the frequency of chronic complaints and chronic complaints that are possibly associated with allergic and non-allergic food hypersensitivity. Because the vast majority of complaints did not occur anymore and the remainder of the complaints decreased in frequency of occurrence, inevitably this improved the quality of life of the individuals that were treated. This study cannot be compared to a full-scale clinical trial in which an intervention is investigated under controlled conditions. Instead, a group of individuals that suffered from chronic complaints participated in an observational study in natural settings. It has to be stressed that the results of this study can be due to the Biophoton aspect of Biophoton Therapy intervention, but may in part be due to the psychosocial context of the treatment situation. This study is aimed to be a first step to investigate if there is an influence of Biophoton Therapy on chronic complaints among children and adolescents and the improvement on their quality of life. Thus, a larger research project among a larger group of individuals is desirable. And to assess the effects over a longer period, further research could be done where the progress of the cooperating individuals is assessed at a regular interval. In this study, the severity of the symptoms is not examined. Instead, the frequency of occurring complaints is examined and can be interpreted as a measure of degree of severity. The frequency of occurrence of the complaints among the children and adolescents serve as a measure of the quality of life. It may also be interesting not only to look at the quality of life, but also to see if Biophoton Therapy affects the symptoms diagnosed by medical doctors. 

The full article can be found at https://healphotonic.com/wp-content/uploads/2021/08/VT_Pet-Reatsch_and_Pet_Biophoton_Therapy_Quality_of_Life_Children_Chronic_Complaints_and_Food_Hypersensitivities2010.pdf

I